Your browser doesn't support javascript.
loading
[COVID-19: Still a place for tocilizumab?] / COVID-19 : encore une place pour le tocilizumab ?
Richier, Q; Plaçais, L; Lacombe, K; Hermine, O.
Affiliation
  • Richier Q; Service de maladies infectieuses, hôpital Saint-Antoine, Assistance publique des Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France. Electronic address: quentin.richier@hotmail.fr.
  • Plaçais L; Service d'hématologie, hôpital Necker, Assistance publique des Hôpitaux de Paris, Paris, France; Sorbonne université, Paris, France.
  • Lacombe K; Service de maladies infectieuses, hôpital Saint-Antoine, Assistance publique des Hôpitaux de Paris, Paris, France; Sorbonne université, Paris, France.
  • Hermine O; Université de Paris, Paris, France; Service d'hématologie, hôpital Necker, Assistance publique des Hôpitaux de Paris, Paris, France; Inserm U 1163, institut Imagine, Paris, France.
Rev Med Interne ; 42(2): 73-78, 2021 02.
Article in Fr | MEDLINE | ID: mdl-33288230
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Humans Language: Fr Journal: Rev Med Interne Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antibodies, Monoclonal, Humanized / COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Humans Language: Fr Journal: Rev Med Interne Year: 2021 Document type: Article Country of publication: